These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 18255198)

  • 1. Homology modeling of MT1 and MT2 receptors.
    Farce A; Chugunov AO; Logé C; Sabaouni A; Yous S; Dilly S; Renault N; Vergoten G; Efremov RG; Lesieur D; Chavatte P
    Eur J Med Chem; 2008 Sep; 43(9):1926-44. PubMed ID: 18255198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular modeling of human MT2 melatonin receptor: the role of Val204, Leu272 and Tyr298 in ligand binding.
    Mazna P; Obsilova V; Jelinkova I; Balik A; Berka K; Sovova Z; Ettrich R; Svoboda P; Obsil T; Teisinger J
    J Neurochem; 2004 Nov; 91(4):836-42. PubMed ID: 15525337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of structure-activity relationships for MT2 selective antagonists by melatonin MT1 and MT2 receptor models.
    Rivara S; Lorenzi S; Mor M; Plazzi PV; Spadoni G; Bedini A; Tarzia G
    J Med Chem; 2005 Jun; 48(12):4049-60. PubMed ID: 15943478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-throughput screening assay for new ligands at human melatonin receptors.
    Yan JH; Su HR; Boutin JA; Renard MP; Wang MW
    Acta Pharmacol Sin; 2008 Dec; 29(12):1515-21. PubMed ID: 19026172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Homology models of melatonin receptors: challenges and recent advances.
    Pala D; Lodola A; Bedini A; Spadoni G; Rivara S
    Int J Mol Sci; 2013 Apr; 14(4):8093-121. PubMed ID: 23584026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular pharmacology of the mouse melatonin receptors MT₁ and MT₂.
    Devavry S; Legros C; Brasseur C; Cohen W; Guenin SP; Delagrange P; Malpaux B; Ouvry C; Cogé F; Nosjean O; Boutin JA
    Eur J Pharmacol; 2012 Feb; 677(1-3):15-21. PubMed ID: 22202844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of proline residues in the structure and function of human MT2 melatonin receptor.
    Mazna P; Grycova L; Balik A; Zemkova H; Friedlova E; Obsilova V; Obsil T; Teisinger J
    J Pineal Res; 2008 Nov; 45(4):361-72. PubMed ID: 18544139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bicyclic melatonin receptor agonists containing a ring-junction nitrogen: Synthesis, biological evaluation, and molecular modeling of the putative bioactive conformation.
    Elsner J; Boeckler F; Davidson K; Sugden D; Gmeiner P
    Bioorg Med Chem; 2006 Mar; 14(6):1949-58. PubMed ID: 16290939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pineal and cortical melatonin receptors MT1 and MT2 are decreased in Alzheimer's disease.
    Brunner P; Sözer-Topcular N; Jockers R; Ravid R; Angeloni D; Fraschini F; Eckert A; Müller-Spahn F; Savaskan E
    Eur J Histochem; 2006; 50(4):311-6. PubMed ID: 17213040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular cloning and pharmacological characterization of rat melatonin MT1 and MT2 receptors.
    Audinot V; Bonnaud A; Grandcolas L; Rodriguez M; Nagel N; Galizzi JP; Balik A; Messager S; Hazlerigg DG; Barrett P; Delagrange P; Boutin JA
    Biochem Pharmacol; 2008 May; 75(10):2007-19. PubMed ID: 18384758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MT1 and MT2 melatonin receptors: ligands, models, oligomers, and therapeutic potential.
    Zlotos DP; Jockers R; Cecon E; Rivara S; Witt-Enderby PA
    J Med Chem; 2014 Apr; 57(8):3161-85. PubMed ID: 24228714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are G protein-coupled receptor heterodimers of physiological relevance?--Focus on melatonin receptors.
    Levoye A; Jockers R; Ayoub MA; Delagrange P; Savaskan E; Guillaume JL
    Chronobiol Int; 2006; 23(1-2):419-26. PubMed ID: 16687315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and pharmacological evaluation of pentacyclic 6a,7-dihydrodiindole and 2,3-dihydrodiindole derivatives as novel melatoninergic ligands.
    Attia MI; Witt-Enderby PA; Julius J
    Bioorg Med Chem; 2008 Aug; 16(16):7654-61. PubMed ID: 18657980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. XFEL structures of the human MT
    Johansson LC; Stauch B; McCorvy JD; Han GW; Patel N; Huang XP; Batyuk A; Gati C; Slocum ST; Li C; Grandner JM; Hao S; Olsen RHJ; Tribo AR; Zaare S; Zhu L; Zatsepin NA; Weierstall U; Yous S; Stevens RC; Liu W; Roth BL; Katritch V; Cherezov V
    Nature; 2019 May; 569(7755):289-292. PubMed ID: 31019305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural basis of the ligand binding and signaling mechanism of melatonin receptors.
    Wang Q; Lu Q; Guo Q; Teng M; Gong Q; Li X; Du Y; Liu Z; Tao Y
    Nat Commun; 2022 Jan; 13(1):454. PubMed ID: 35075127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and functional characterization of substituted isoquinolinones as MT2-selective melatoninergic ligands.
    Hu Y; Chan KH; He X; Ho MK; Wong YH
    PLoS One; 2014; 9(12):e113638. PubMed ID: 25479338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence that membrane-bound G protein-coupled melatonin receptors MT1 and MT2 are not involved in the neuroprotective effects of melatonin in focal cerebral ischemia.
    Kilic U; Yilmaz B; Ugur M; Yüksel A; Reiter RJ; Hermann DM; Kilic E
    J Pineal Res; 2012 Mar; 52(2):228-35. PubMed ID: 21913972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New coumarin-based fluorescent melatonin ligands. Design, synthesis and pharmacological characterization.
    de la Fuente Revenga M; Herrera-Arozamena C; Fernández-Sáez N; Barco G; García-Orue I; Sugden D; Rivara S; Rodríguez-Franco MI
    Eur J Med Chem; 2015 Oct; 103():370-3. PubMed ID: 26367450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A molecular and chemical perspective in defining melatonin receptor subtype selectivity.
    Chan KH; Wong YH
    Int J Mol Sci; 2013 Sep; 14(9):18385-406. PubMed ID: 24018885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-(substituted-anilinoethyl)amides: design, synthesis, and pharmacological characterization of a new class of melatonin receptor ligands.
    Rivara S; Lodola A; Mor M; Bedini A; Spadoni G; Lucini V; Pannacci M; Fraschini F; Scaglione F; Sanchez RO; Gobbi G; Tarzia G
    J Med Chem; 2007 Dec; 50(26):6618-26. PubMed ID: 18052314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.